Revilab Peptide 06

Dosage form Application area Recommendations for use Contraindications Manufacturer
Read on
Certificate number:RU.77.99.88.003.Е.003809.08.16
Date of registration and renewal:29.08.2016
Dosage form: & nbspTablets without a shell weighing 350 mg, tablets in a water-soluble shell weighing 370 mg, capsules of 350 mg.
Classification "Composition" & nbsp BAD - products of plant, animal or mineral origin
Classification "Clinical" & nbsp BAA sources of fatty acids
Composition: & nbspOmega-3 acids, artichoke leaves extract, strawberry leaves extract, plantain leaf extract, AA-11 peptide complex, AA-15 peptide complex, AA-10 peptide complex, E460, lactose monohydrate, maltodextin or dextrose, E470a, E551, water-soluble membrane tablets (E904, E464, E171, E1521), the composition of the capsule shell (gelatin, E171).
Scope: & nbspFor realization to the population as a biologically active additive to food - a source of glycyrrhizic acid.
Suggested Usage: & nbspAdults: 1 capsule / 1 tablet daily with meals. Duration of admission 4-6 weeks. If necessary, the reception can be repeated. Repeated receptions are possible throughout the year.
Contraindications:Individual intolerance of components, pregnancy, breast-feeding. Before use, it is recommended to consult a doctor.
Shelf life:3 years.
Storage conditions:Store in original original packaging in a dry place inaccessible to children, at a temperature not exceeding 25 ° C.
Research protocols:Expert Opinion of the Federal Antimonopoly Service of the Russian Federation "ФЦГиЭ Роспотребнадзора" №10-2ФЦ / 2115 of August 25, 2016.
Recipient:SPC, OOOSPC, OOO Russian Federation
Information update date: & nbsp12.10.2016
Instructions
Up